Evidence map›Paper›PMID 32478309›Full record

ArticleGates open research2019

Intervening along the spectrum of tuberculosis: meeting report from the World TB Day nanosymposium in the Institute of Infectious Disease and Molecular Medicine at the University of Cape Town.

Sabelo Hadebe, Melissa Chengalroyen, Reto Guler, Kehilwe Nakedi, Anastasia Koch, Mohau Makatsa, Muki Shey, Suraj P Parihar, Bryan Bryson, Mohlopheni J Marakalala and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gates open research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Sabelo HadebeDivision of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine (IDM), Cape Town, Westen Cape, 7925, South Africa.ORCID https://orcid.org/0000-0002-6049-8395
Melissa ChengalroyenSAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Molecular Mycobacteriology unit, Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Disease and Molecular Medicine based (IDM), University of Cape Town, Cape Town, Western Cape, 7925, South Africa.
Reto GulerDivision of Immunology and South African Medical Research Council (SAMRC) Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine (IDM), Cape Town, Westen Cape, 7925, South Africa.
Kehilwe NakediDivision of Chemical and Systems Biology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, Western Cape, 7925, South Africa.
Anastasia KochSAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Molecular Mycobacteriology unit, Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Disease and Molecular Medicine based (IDM), University of Cape Town, Cape Town, Western Cape, 7925, South Africa.
Mohau MakatsaDivision of Medical Virology, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, Westen Cape, 7925, South Africa.
Muki SheyWellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Diseases and Molecular Medicine (IDM) & Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, Western Cape, 7925, South Africa.ORCID https://orcid.org/0000-0002-8776-4737
Suraj P PariharWellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Diseases and Molecular Medicine (IDM) & Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, Western Cape, 7925, South Africa.
Bryan BrysonMIT Biological Engineering, Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, MA 02142, USA.ORCID https://orcid.org/0000-0003-1716-6712
Mohlopheni J MarakalalaAfrica Health Research Institute, South Africa, Durban, KwaZulu Natal, South Africa.
Hlumani NdlovuDivision of Chemical and Systems Biology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, Western Cape, 7925, South Africa.ORCID https://orcid.org/0000-0003-0137-1439
University of Cape Town · ZASouth African Medical Research Council · ZAAfrica Health Research Institute · ZARagon Institute of MGH, MIT and Harvard · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

Tuberculosis (TB), caused by the highly infectious

Indexed as

Host directed Therapiesnew toolsTB/HIV co-infectionstransmissionTuberculosis

Identifiers

PMID32478309
PMCPMC7241047
OpenAlexW2952222253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.